Case study

Multicentre observational study on optimising the oncology care pathway

Background

A multicentre observational study in oncology was conducted to optimise the care pathway of patients with breast cancer. Carried out in four hospitals and involving 78 patients, the study set out to analyse the care pathway and identify the main areas for improvement. Its objectives included assessing the coordination between the different stakeholders involved in patient care, as well as the organisation of the various stages of the care pathway. The study also looked at the medico-economic organisation of healthcare facilities, in order to better understand potential difficulties and opportunities to improve patient care.

Discover our services

essai clinique international en maladie rare projet national de centralisation de données clinique en vie réelle, étude clinique de bioéquivalence, Étude clinique sur le diabète étude clinique sur la sécurité d'un agent de contraste

étude observationnelle multicentrique en oncologie

Challenges identified

The main challenges were:

consistent collection of patient follow-up data,
prompt and complete entry into the electronic case report form (eCRF),
and standardisation of information across the participating sites.

Working directly with patients required an approach that was both human and methodical, ensuring the reliability of the data collected and the consistency of the recorded care pathways. This approach was fully in line with the requirements of oncology clinical studies, where the quality of data collection and the accuracy of information are essential to monitoring care pathways.

Pharmaspecific’s role

Pharmaspecific provided an active on-site presence through its dedicated team member, who met patients during their visits, collected clinical and organisational information and completed the eCRFs in real time. This close presence on the ground ensured accurate data collection that faithfully reflected clinical reality, while easing the workload of hospital teams and helping to ensure compliance with Good Clinical Practice (GCP).

étude observationnelle multicentrique en oncologie essai clinique de phase III en myélome multiple ; étude de syndromes coronaires aigus

Results

étude observationnelle multicentrique en oncologie essai clinique de phase II en oncologie thoracique étude clinique de sécurité post-autorisation essai clinique international de phase III en lymphome

Key takeaways

This project illustrates the ability of Pharmaspecific to:

Bring its teams as close as possible to patients

Strengthen the quality and consistency of field data

Actively contribute to studies aimed at improving the oncology care pathway.

Through this assignment, Pharmaspecific confirms its expertise in oncology clinical research applied to hospital practice, as well as its commitment to patient-centred research based on the quality, reliability and relevance of the data collected.

Medical Services